About HUM-MOLGEN
HUM-MOLGEN is a Healthcare company. It operates as a human molecular genetics communication and resources are offered through HUM-MOLGEN for professionals in the field. HUM-MOLGEN offers products and services including Genetic News Service and Bioinformatics Tools. Its focus areas include Biotechnology, Genetics, Molecular Genetics and Research and Communication.
Company details
HUM-MOLGEN is recognized as a central portal that serves as an international communication forum in human molecular genetics, connecting scientists and professionals from 86 countries. Information on genetic news, bioinformatics, biotechnology, literature, journals, ethics, positions, and events is provided to support global collaboration. Opportunities for editorial support and sponsorship are sought, while professional requests like research collaborations and molecular tests are integrated. The platform facilitates updates and interactions without offering direct referrals for genetic diseases, directing users to official health resources instead.
- SectorsHealthcare
- Email••••••••
- Legal Name Hum-Molgen
Products & Services of HUM-MOLGEN
HUM-MOLGEN offers a comprehensive portfolio of products and services, including Genetic News Service and Bioinformatics Tools.
News and updates in human molecular genetics are provided to facilitate communication among professionals worldwide
A selection of external bioinformatic tools is offered to support research and analysis in genetics and biotechnology
Web traffic of HUM-MOLGEN
Websites that share an audience with HUM-MOLGEN (hum-molgen.org).
Websites whose visitors overlap most with HUM-MOLGEN. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| immunobiochem.com | 100% | – | – | View details | |
| rbcbioscience.com | 90% | – | – | View details | |
| decode.com | 74% | 13.6K | #1,966,785 | View details |
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as HUM-MOLGEN (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about HUM-MOLGEN
HUM-MOLGEN is recognized as a central portal that serves as an international communication forum in human molecular genetics, connecting scientists and professionals from 86 countries. Information on genetic news, bioinformatics, biotechnology, literature, journals, ethics, positions, and events is provided to support global collaboration. Opportunities for editorial support and sponsorship are sought, while professional requests like research collaborations and molecular tests are integrated. The platform facilitates updates and interactions without offering direct referrals for genetic diseases, directing users to official health resources instead.
HUM-MOLGEN offers Genetic News Service and Bioinformatics Tools.
HUM-MOLGEN operates through Hum-Molgen.